Diagnostic products
Digital Life Platform from ICarbonX helps clinicians in early screening, preventive intervention, prognosis tracking, and precision medicine in various diseases including cancer and other disorders such as hypertension, cardiovascular diseases,…
Integrates AI to ultrasound technology for early disease identification. Description The system guides providers through the ultrasound process in real time to produce diagnostic-quality images that the software then helps…
Helps to improve personalized analysis and treatment of heart disease and cardiovascular care using AI technology. Description The company’s AI-enabled platform measures and analyzes atherosclerosis, which is a buildup of…
Arterys provides products for early diagnoses and precision medicine. Description The company’s AI-enabled imaging platform helps in detection of breast cancer, analyses of cardiac MRI images, reading of emergency department…
To assist pathologists in making more accurate diagnoses including in cancer diagnosis and methods for individualized treatment. Description AISightTM from PathAI is a cloud-native intelligent enterprise workflow solution used by laboratories…
Viz.ai helps care teams react faster with AI-powered healthcare solutions that can detect issues and notify care teams quickly for faster decisions and interventions. Description Viz.ai solutions such as Viz.ai…
SKOUT from Iterative Health uses AI-enabled system to improve disease diagnosis and treatment in gastroenterology. Description The company’s system helps doctors identify potentially cancerous polyps. Their system equally automates the…
Tradename: Elecsys HIV Duo Proper Name: Elecsys HIV Duo Indication: Intended to screen individual human donors, including volunteer donors of whole blood, blood components and source plasma. The assay is…
Drug Name: Posluma Indications: To use with positron emission tomography imaging in certain patients with prostate cancer. Active Ingredient: Flotufolastat F 18 Company: Blue Earth Diagnostics Ltd. Approval Date: 5/25/2023…
Tempus, a leader in artificial intelligence and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s first Premarket Approval (PMA) application for its…